People · Operator
Named in public records as an officer, director or promoter · active 2014–2025 · Biotechnology, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| CryOSA, Inc. | — | Biotechnology | Series A | $7.0M | $19.5M | 2025 |
| Convenience Network, Inc. | — | Other | Pre-Seed | $853K | $19.7M | 2014 |
David Belitz at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David Belitz on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| James Eadie | 1 | 6 |
| Donald Gonzales | 1 | 3 |
| Steve Newman | 1 | 3 |
| Douglas Yoakley | 1 | 2 |
| Doug French | 1 | 2 |
| Laura Stoltenberg | 1 | 1 |
| Michael Hatcher | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.